1. Home
  2. LICN vs GKOS Comparison

LICN vs GKOS Comparison

Compare LICN & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lichen China Limited

LICN

Lichen China Limited

HOLD

Current Price

$3.16

Market Cap

53.1M

Sector

N/A

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$116.18

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LICN
GKOS
Founded
2004
1998
Country
China
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.1M
5.4B
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
LICN
GKOS
Price
$3.16
$116.18
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$125.54
AVG Volume (30 Days)
63.2K
831.6K
Earning Date
12-19-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,641,000.00
$469,820,000.00
Revenue This Year
N/A
$31.15
Revenue Next Year
N/A
$24.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.38
52 Week Low
$2.57
$73.16
52 Week High
$56.42
$163.71

Technical Indicators

Market Signals
Indicator
LICN
GKOS
Relative Strength Index (RSI) 44.92 72.56
Support Level $3.01 $112.67
Resistance Level $3.36 $118.17
Average True Range (ATR) 0.48 3.17
MACD 0.02 0.04
Stochastic Oscillator 9.10 79.58

Price Performance

Historical Comparison
LICN
GKOS

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: